168 related articles for article (PubMed ID: 17482391)
1. Biopharmaceutics of 13-cis-retinoic acid (isotretinoin) formulated with modified beta-cyclodextrins.
Lin HS; Leong WW; Yang JA; Lee P; Chan SY; Ho PC
Int J Pharm; 2007 Aug; 341(1-2):238-45. PubMed ID: 17482391
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
Yap KL; Liu X; Thenmozhiyal JC; Ho PC
Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
[TBL] [Abstract][Full Text] [Related]
3. Solubilization of vorinostat by cyclodextrins.
Cai YY; Yap CW; Wang Z; Ho PC; Chan SY; Ng KY; Ge ZG; Lin HS
J Clin Pharm Ther; 2010 Oct; 35(5):521-6. PubMed ID: 20831676
[TBL] [Abstract][Full Text] [Related]
4. The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol.
Das S; Lin HS; Ho PC; Ng KY
Pharm Res; 2008 Nov; 25(11):2593-600. PubMed ID: 18629618
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer.
Gundogdu E; Koksal C; Karasulu E
Drug Dev Ind Pharm; 2012 Jun; 38(6):689-96. PubMed ID: 22010782
[TBL] [Abstract][Full Text] [Related]
6. Kinetic study of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of all-trans-retinoic acid in Sprague-Dawley rats after oral or intravenous administration.
Lin HS; Chan SY; Low KS; Shoon ML; Ho PC
J Pharm Sci; 2000 Feb; 89(2):260-7. PubMed ID: 10688755
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation.
Zhao Y; Sun C; Shi F; Firempong CK; Yu J; Xu X; Zhang W
Pharm Biol; 2016; 54(1):130-8. PubMed ID: 25853954
[TBL] [Abstract][Full Text] [Related]
8. Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability.
Lin HS; Ho PC
J Pharm Sci; 2011 Oct; 100(10):4491-500. PubMed ID: 21520090
[TBL] [Abstract][Full Text] [Related]
9. Novel formulation strategies for enhancing oral delivery of methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-β-cyclodextrin.
Mekjaruskul C; Yang YT; Leed MG; Sadgrove MP; Jay M; Sripanidkulchai B
Int J Pharm; 2013 Mar; 445(1-2):1-11. PubMed ID: 23376503
[TBL] [Abstract][Full Text] [Related]
10. Enhanced aqueous solubility and bioavailability of capsaicin by the preparation of an inclusion complex.
Chen X; Sun X; Ren K; Zhang X; Zhang Z; Gong T
Arzneimittelforschung; 2010; 60(9):571-4. PubMed ID: 21117501
[TBL] [Abstract][Full Text] [Related]
11. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
12. Biopharmaceutics of beta-cyclodextrin derivative-based formulations of acitretin in Sprague-Dawley rats.
Liu X; Lin HS; Chan SY; Ho PC
J Pharm Sci; 2004 Apr; 93(4):805-15. PubMed ID: 14999719
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
14. Characterization and in vitro evaluation of freeze-dried microparticles composed of granisetron-cyclodextrin complex and carboxymethylcellulose for intranasal delivery.
Cho HJ; Balakrishnan P; Shim WS; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2010 Nov; 400(1-2):59-65. PubMed ID: 20801202
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
[TBL] [Abstract][Full Text] [Related]
16. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits.
Mannila J; Järvinen T; Järvinen K; Tarvainen M; Jarho P
Eur J Pharm Sci; 2005 Sep; 26(1):71-7. PubMed ID: 15955678
[TBL] [Abstract][Full Text] [Related]
17. The effect of hydroxypropyl-beta-cyclodextrin and sucrose on the sublingual absorption of midazolam in rabbits.
Kaartama R; Turunen E; Toljamo K; Kokki H; Lehtonen M; Ranta VP; Savolainen J; Järvinen K; Jarho P
Eur J Pharm Biopharm; 2012 May; 81(1):178-83. PubMed ID: 22321528
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of 16-dehydropregnenolone hydroxypropyl-β-cyclodextrin inclusion complex following peroral administration.
Sun Y; Jia L; Zhou H; Mao M; Wang X; Wei L; Sun L
Pharm Dev Technol; 2017 Mar; 22(2):218-228. PubMed ID: 27269370
[TBL] [Abstract][Full Text] [Related]
19. 2-hydroxypropyl-beta-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid.
Lin HS; Chean CS; Ng YY; Chan SY; Ho PC
J Clin Pharm Ther; 2000 Aug; 25(4):265-9. PubMed ID: 10971776
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of albumin, triglycerides, total protein and glucose in rats are altered after oral treatment with low doses of 13-cis-retinoic acid or all-trans-retinoic acid.
Cisneros FJ; Gough BJ; Patton RE; Ferguson SA
J Appl Toxicol; 2005; 25(6):470-8. PubMed ID: 16092084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
